Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-18 to 2024-01-10
Current total value of award: $1950.6
Description: 4563161650!OZURDEX 0.7 MG IMPLANTS